Pterygium Clinical Trial
Official title:
The Use of Pentacam in Assessment of Corneal Changes After Pterygium Excision
Aim of this study is to assess the corneal changes before and after pterygium excision by using pentacam system.
Pterygium is a dysplasia of the bulbar conjunctiva extending onto the corneal surface. The
prevelance of pterygium ranges from 0.7% to 31% in various populations according to the
location, altitude, and race. It has a higher prevelance in areas which have increased
exposure to direct sun with ultraviolet (UV) B light. Patients with pterygia present with
variety of complaints ,ranging from asymptomatic to significant redness ,swelling ,itching
,irritation and blurring of vision associated with elevated lesions of the conjunctiva and
contiguous cornea in one or both eyes.The induction of astigmatism due to the invasion of the
pterygium into the cornea as well as changes in corneal curvature and refractive status has
been reported by numerous studies.
Multiple different procedures have been advocated in the treatment of pterygia. These
procedures range from simple excision to sliding flaps of conjunctiva with or without
adjunctive external beta radiation therapy and/or use of topical chemotherapeutic agents,
such as Mitomycin C.
Pentacam is a rotating Scheimpflug camera which measures Scheimpflug images of the anterior
eye segment. With the pentacam, topographic analysis of the corneal front and back surfaces
is based on the true elevation measurement from one side of the cornea to the other (limbus
to limbus). Pentacam also describes the true thickness of the cornea across its entire
breadth and width.
Type of the study: prospective observational longitudinal study
Study Setting: Assuit University Hospital ( ophthalmology Department ) Assuit Police Hospital
( ophthalmology Department )
Study subjects:
1. Inclusion criteria:
- The study will include 30 eyes of adult subjects.
- All eyes have primary pterygium and seeking for surgery due to Cosmetic problems,
ocular irritation, and, or visual impairment.
- All selected patients will undergo complete ophthalmological examination including
refraction, best corrected visual acuity, keratometry, and pentacam (scheimpflug
imaging) preoperatively then will be followed up 2 and 6 months post pterygium
excision.
2. Exclusion criteria:
- patients with recurrent pterygium.
- Patients with media opacities:
- Dense cataract. - Corneal opacities.
- Patients with a history of intraocular surgery ,ocular trauma ,and contact lens
wear.
- Patients with severe ocular surface disorders as Stevens-Johnson syndrome.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT02641132 -
Pterygium Head Body MMC1: Two Different Surgical Procedures and Their Effect on Endothelial Cell Count.
|
Phase 4 | |
Completed |
NCT02342392 -
Intralesional Ranibizumab on Pterygium Vascularity, Size and Recurrence Rate: a Pilot Study
|
Phase 2/Phase 3 | |
Recruiting |
NCT01387971 -
Using Impression Cytology to Observe the Cytological Changes of Ocular Surface Cells in Various Ocular Surface Disorders
|
N/A | |
Recruiting |
NCT05978687 -
The Use of Lidocaine Gel Versus Subconjunctival Xylocaine Injection in Pterygium Excision
|
Phase 4 | |
Not yet recruiting |
NCT06042296 -
Expression of CD44, PCNA and E-cadherin in Pterygium Tissue
|
||
Completed |
NCT04022811 -
Effect of Bromfenac on Pain Related to Pterygium Surgery
|
Phase 4 | |
Recruiting |
NCT01261455 -
Prospective Randomized Pilot Study Comparing Inferior Versus Superior Conjunctival Autografts for Primary Pterygia
|
N/A | |
Recruiting |
NCT01249235 -
Bandage Contact Lens and Oral Analgesics Versus Patching and Oral Analgesics for Pain Following Pterygium Surgery
|
N/A | |
Completed |
NCT01115517 -
Safety Study of Avastin Used as Adjunctive Therapy in Pterygium Surgery
|
Phase 2 | |
Completed |
NCT00768963 -
Ranibizumab for the Inhibition of Neovascularization in Pterygia
|
Phase 1 | |
Completed |
NCT00949728 -
Conjunctival Autologous Transplantation Using Fibrin Glue in Primary Pterygia
|
N/A | |
Recruiting |
NCT00563277 -
Surgical Treatment of Concurrent Cataract and Primary Pterygium
|
N/A | |
Completed |
NCT00346450 -
Autologous ex Vivo Conjunctival Epithelial Cell Expansion for Ocular Surface Transplantation
|
Phase 3 | |
Completed |
NCT03533244 -
A Study of the Response to AG-86893 in Patients With Pterygium Hyperemia
|
Phase 2 | |
Completed |
NCT04403516 -
Dextenza in Pterygium Surgery
|
Phase 4 | |
Recruiting |
NCT02911532 -
Tissue Engineering Conjunctiva for the Treatment of Pterygium and Atretoblepharia
|
N/A | |
Unknown status |
NCT02015000 -
Surgical Result of Pterygium Extended Removal Followed by Fibrin Glue Assisted Amniotic Membrane Transplantation
|
N/A | |
Completed |
NCT00344201 -
Assessment of Fibrin Glue in Pterygium Surgery and Other Forms of External Eye Surgery
|
Phase 1 | |
Recruiting |
NCT00326560 -
Comparison of Glue With Sutures for Pterygium Surgery
|
Phase 3 | |
Not yet recruiting |
NCT03314389 -
The Corneal and Conjunctiva Sensation Before and After Pterygium Surgeries
|
N/A |